Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
8.34
+0.16 (1.96%)
At close: May 9, 2025, 4:00 PM
8.26
-0.08 (-0.96%)
After-hours: May 9, 2025, 4:09 PM EDT
Bicycle Therapeutics Revenue
Bicycle Therapeutics had revenue of $9.98M in the quarter ending March 31, 2025, a decrease of -48.91%. This brings the company's revenue in the last twelve months to $25.72M, down -38.18% year-over-year. In the year 2024, Bicycle Therapeutics had annual revenue of $35.28M with 30.76% growth.
Revenue (ttm)
$25.72M
Revenue Growth
-38.18%
P/S Ratio
21.03
Revenue / Employee
$84,334
Employees
305
Market Cap
577.58M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BCYC News
- 5 days ago - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 9 days ago - Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results - Business Wire
- 11 days ago - Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025 - Business Wire
- 19 days ago - Bicycle Therapeutics: Maybe Underwhelming, But I Don't Think They Should Be This Discounted - Seeking Alpha
- 5 weeks ago - Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 6 weeks ago - Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments - Business Wire
- 2 months ago - Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 3 months ago - Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire